Patricia L Morris

Array ( [id] => 8621626 [patent_doc_number] => 08354541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Optical purification of esomeprazole' [patent_app_type] => utility [patent_app_number] => 12/742531 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2408 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12742531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7978067 [patent_doc_number] => 08071781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Process for preparing rabeprazole sodium' [patent_app_type] => utility [patent_app_number] => 12/268580 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3274 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 265 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071781.pdf [firstpage_image] =>[orig_patent_app_number] => 12268580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509364 [patent_doc_number] => 20090082571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Intermediates of 2-substituted carbapenem derivatives and process for production thereof' [patent_app_type] => utility [patent_app_number] => 12/289750 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31789 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082571.pdf [firstpage_image] =>[orig_patent_app_number] => 12289750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097841 [patent_doc_number] => 20110003822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 12/740098 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24112 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003822.pdf [firstpage_image] =>[orig_patent_app_number] => 12740098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331346 [patent_doc_number] => 20090111823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'AMINOPYRIDINE DERIVATIVES AS MODULATORS OF MGLUR5' [patent_app_type] => utility [patent_app_number] => 12/258165 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9632 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111823.pdf [firstpage_image] =>[orig_patent_app_number] => 12258165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603624 [patent_doc_number] => 20100292482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'NOVEL PRECURSORS' [patent_app_type] => utility [patent_app_number] => 12/739669 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4259 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292482.pdf [firstpage_image] =>[orig_patent_app_number] => 12739669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662380 [patent_doc_number] => 20110311649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'NOVEL IMIDAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/739852 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14558 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311649.pdf [firstpage_image] =>[orig_patent_app_number] => 12739852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331380 [patent_doc_number] => 20090111857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => '1,2,4-TRIAZOLE ETHER DERIVATIVES AS MODULATORS OF MGLUR5' [patent_app_type] => utility [patent_app_number] => 12/258119 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11693 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111857.pdf [firstpage_image] =>[orig_patent_app_number] => 12258119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6516641 [patent_doc_number] => 20100216846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'TRISUBSTITUTED 1,2,4 TRIAZOLES' [patent_app_type] => utility [patent_app_number] => 12/738763 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14829 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216846.pdf [firstpage_image] =>[orig_patent_app_number] => 12738763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417061 [patent_doc_number] => 20090042948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester' [patent_app_type] => utility [patent_app_number] => 12/247678 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2576 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042948.pdf [firstpage_image] =>[orig_patent_app_number] => 12247678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6511907 [patent_doc_number] => 20100210848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'PROCESS FOR OPTICALLY ACTIVE SULFOXIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/681386 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7300 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210848.pdf [firstpage_image] =>[orig_patent_app_number] => 12681386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 152312 [patent_doc_number] => 07678919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Method for producing pentacyclic taxans' [patent_app_type] => utility [patent_app_number] => 12/238070 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14810 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678919.pdf [firstpage_image] =>[orig_patent_app_number] => 12238070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546765 [patent_doc_number] => 20090156642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => '5-Membered heterocyclic compound' [patent_app_type] => utility [patent_app_number] => 12/284636 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 141401 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156642.pdf [firstpage_image] =>[orig_patent_app_number] => 12284636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441995 [patent_doc_number] => 20090093634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Substituted pyrroline kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/284371 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16514 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093634.pdf [firstpage_image] =>[orig_patent_app_number] => 12284371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9469079 [patent_doc_number] => 08722710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Deuterium-enriched pioglitazone' [patent_app_type] => utility [patent_app_number] => 12/233751 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3651 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12233751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310890 [patent_doc_number] => 20090018171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'IMIDAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/211849 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7146 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018171.pdf [firstpage_image] =>[orig_patent_app_number] => 12211849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760154 [patent_doc_number] => 08420676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Oxazolidinone derivatives' [patent_app_type] => utility [patent_app_number] => 12/211655 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16422 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12211655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272289 [patent_doc_number] => 20090076065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED MK-0812' [patent_app_type] => utility [patent_app_number] => 12/208970 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3455 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076065.pdf [firstpage_image] =>[orig_patent_app_number] => 12208970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272311 [patent_doc_number] => 20090076087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED ETORICOXIB' [patent_app_type] => utility [patent_app_number] => 12/208888 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2987 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076087.pdf [firstpage_image] =>[orig_patent_app_number] => 12208888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272317 [patent_doc_number] => 20090076093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED ROSIGLITAZONE' [patent_app_type] => utility [patent_app_number] => 12/206316 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3657 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076093.pdf [firstpage_image] =>[orig_patent_app_number] => 12206316 [rel_patent_id] =>[rel_patent_doc_number] =>)